Home › Neuroendocrine Carcinoma › Florida
Neuroendocrine Carcinoma clinical trials in Florida
5 studies for Neuroendocrine Carcinoma are looking for participants at sites in Florida.
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- Moffitt Cancer Center, Tampa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07278479Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
- University of Florida, Gainesville
RecruitingPhase 1/2
Ages 18 to 99 · All sexes · Updated Jul 13, 2026 · NCT05000294A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07174583A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Memorial Healthcare System, Hollywood
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)
- University of Miami, Miami
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT06889493From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.